US FDA Transparency Win: Sponsors Know More Product-Specific Guidances Coming, Requests Fall

 
• By Derrick Gingery
  
transparency
Generic drug sponsors use the anticipated PSG list to validate development portfolios. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics